Researchers involved in a federally funded clinical trial on marijuana highlight the critical importance of further study into the substance, given its widespread use. They argue that classifying cannabis as a Schedule I substance creates a paradox, as it heavily restricts the very studies needed to prove its medical value. The researchers advocate for moving marijuana to Schedule III to ease restrictions, increase NIH funding, and improve access to government-approved cannabis supplies. They also point out obstacles such as systemic underfunding, institutional hesitancy due to stigma, navigating multiple federal agencies, and limited supply of NIDA-approved marijuana. The article emphasizes that reform is crucial to close the evidence gap and address public health concerns.

Science Can’t Keep Up with Legalization While the Feds Keep Marijuana in a Schedule I Loophole

Jul 3, 2025

Source:

Ben Adlin

Marijuana Moment

University of Maryland researchers are calling out the federal government for a major contradiction: the DEA demands proof of marijuana’s medical benefits while keeping it in Schedule I, which makes that very research nearly impossible. A new article in the American Journal of Medicine highlights how red tape, systemic underfunding, and limited access to quality cannabis "stifle" the scientific community. Lead author Dr. Raya Elfadel Kheirbek shared that her team faced endless delays and massive costs just to study cannabis as a treatment for dementia patients. Scientists argue that moving weed to Schedule III and reviving stalled legislation are essential steps to finally catch up with the reality of widespread legalization.

This matters to every toker because without legitimate federal research, we’re left with a massive "evidence gap." Proper studies mean better safety data, more consistent products, and the eventual dismantling of the stigma that still blocks progress. For the community, having ivory-tower scientists fighting to prove what we already know is a huge win for long-term accessibility and legitimacy.

Recent Reviews

Vanilla Velvet x 06 OG - Jungle Boys, St. Petersburg (Florida Medical)

Upon first glance, Vanilla Velvet from Jungle Boys in St. Pete, Florida, looks like a premium treat—super frosty buds with a vibrant mix of purple and green hues that scream quality craftsmanship. It will undoubtedly lead to potent sessions, but doesn't overwhelm the senses right out of the gate. It's sort of like a velvet rope to a VIP lounge of relaxation...